Need a specific person's email?
Browse ImmunoBrain's employee directory (about 18 employees) and reveal verified emails free.
ImmunoBrain's most common email format is First.Last@ibcheckpoint.com (ex. John.Doe@ibcheckpoint.com), used for 100% of ibcheckpoint.com addresses. ImmunoBrain uses 2 email patterns across 2 domains: ibcheckpoint.com and immunobrain.com. Percentages are the share of addresses within each domain.
| Format | Example | Share of ibcheckpoint.com |
|---|---|---|
| First.Last@ibcheckpoint.comMost common | John.Doe@ibcheckpoint.com |
| Format | Example | Share of immunobrain.com |
|---|---|---|
| First.Last@immunobrain.comMost common | John.Doe@immunobrain.com |
Browse ImmunoBrain's employee directory (about 18 employees) and reveal verified emails free.
Biotechnology ResearchNew York, United States11-50 Employees
ImmunoBrain is a clinical-stage biotechnology company based in New York, focused on neurodegenerative diseases and aging by modulating the immune system. It aims to restore communication among brain immune cells and enhance the brain's natural repair processes, with its lead program centered on an antibody that targets the PD-1/PD-L1 immune checkpoint to address Alzheimer's disease. Its scientific approach draws on discoveries from Prof. Michal Schwartz's laboratory at the Weizmann Institute of Science. In March 2026, ImmunoBrain disclosed Phase 1b data for its IBC-Ab002 antibody and announced related presentations at the AD/PD conference in Copenhagen. These activities reflect ongoing clinical-stage development in neurodegeneration and immunotherapy.
Most common format
First.Last@ibcheckpoint.com
Example: John.Doe@ibcheckpoint.com
Free with a LeadIQ account. No credit card.
Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.